1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CELLECTIS - ADR
2.69 -0.10 (-3.58%)
68,957

XNAS 06 Aug, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The board meeting for Cellectis (ADR) is scheduled for today, for the purpose of Cellectis SA Second Quarter Earnings Results for 2026 See details

Cellectis (ADR) - CLLS - stock price prediction, stock price target, analyst ratings from 5 analysts

Cellectis (ADR) has a share price target of US$ 8, revenue growth forecast of -28.3%, and profit growth estimate of -33.5% for FY26, based on top 5 analyst calls.